CHORUS Deliverable 2.1: State of the Art on Multimedia Search Engines

Based on the information provided by European projects and national initiatives related to multimedia search as well as domains experts that participated in the CHORUS Think-thanks and workshops, this document reports on the state of the art related to multimedia content search from, a technical, and socio-economic perspective. The technical perspective includes an up to date view on content based indexing and retrieval technologies, multimedia search in the context of mobile devices and peer-to-peer networks, and an overview of current evaluation and benchmark inititiatives to measure the performance of multimedia search engines. From a socio-economic perspective we inventorize the impact and legal consequences of these technical advances and point out future directions of research

COMPUTATIONAL TOOLS FOR THE DYNAMIC CATEGORIZATION AND AUGMENTED UTILIZATION OF THE GENE ONTOLOGY

Ontologies provide an organization of language, in the form of a network or graph, which is amenable to computational analysis while remaining human-readable. Although they are used in a variety of disciplines, ontologies in the biomedical field, such as Gene Ontology, are of interest for their role in organizing terminology used to describe—among other concepts—the functions, locations, and processes of genes and gene-products. Due to the consistency and level of automation that ontologies provide for such annotations, methods for finding enriched biological terminology from a set of differentially identified genes in a tissue or cell sample have been developed to aid in the elucidation of disease pathology and unknown biochemical pathways. However, despite their immense utility, biomedical ontologies have significant limitations and caveats. One major issue is that gene annotation enrichment analyses often result in many redundant, individually enriched ontological terms that are highly specific and weakly justified by statistical significance. These large sets of weakly enriched terms are difficult to interpret without manually sorting into appropriate functional or descriptive categories. Also, relationships that organize the terminology within these ontologies do not contain descriptions of semantic scoping or scaling among terms. Therefore, there exists some ambiguity, which complicates the automation of categorizing terms to improve interpretability. We emphasize that existing methods enable the danger of producing incorrect mappings to categories as a result of these ambiguities, unless simplified and incomplete versions of these ontologies are used which omit problematic relations. Such ambiguities could have a significant impact on term categorization, as we have calculated upper boundary estimates of potential false categorizations as high as 121,579 for the misinterpretation of a single scoping relation, has_part, which accounts for approximately 18% of the total possible mappings between terms in the Gene Ontology. However, the omission of problematic relationships results in a significant loss of retrievable information. In the Gene Ontology, this accounts for a 6% reduction for the omission of a single relation. However, this percentage should increase drastically when considering all relations in an ontology. To address these issues, we have developed methods which categorize individual ontology terms into broad, biologically-related concepts to improve the interpretability and statistical significance of gene-annotation enrichment studies, meanwhile addressing the lack of semantic scoping and scaling descriptions among ontological relationships so that annotation enrichment analyses can be performed across a more complete representation of the ontological graph. We show that, when compared to similar term categorization methods, our method produces categorizations that match hand-curated ones with similar or better accuracy, while not requiring the user to compile lists of individual ontology term IDs. Furthermore, our handling of problematic relations produces a more complete representation of ontological information from a scoping perspective, and we demonstrate instances where medically-relevant terms--and by extension putative gene targets--are identified in our annotation enrichment results that would be otherwise missed when using traditional methods. Additionally, we observed a marginal, yet consistent improvement of statistical power in enrichment results when our methods were used, compared to traditional enrichment analyses that utilize ontological ancestors. Finally, using scalable and reproducible data workflow pipelines, we have applied our methods to several genomic, transcriptomic, and proteomic collaborative projects

Machine Learning Methodologies for Interpretable Compound Activity Predictions

Machine learning (ML) models have gained attention for mining the pharmaceutical data that are currently generated at unprecedented rates and potentially accelerate the discovery of new drugs. The advent of deep learning (DL) has also raised expectations in pharmaceutical research. A central task in drug discovery is the initial search of compounds with desired biological activity. ML algorithms are able to find patterns in compound structures that are related to bioactivity, the so-called structure-activity relationships (SARs). ML-based predictions can complement biological testing to prioritize further experiments. Moreover, insights into model decisions are highly desired for further validation and identification of activity-relevant substructures. However, the interpretation of complex ML models remains essentially prohibitive. This thesis focuses on ML-based predictions of compound activity against multiple biological targets. Single-target and multi-target models are generated for relevant tasks including the prediction of profiling matrices from screening data and the discrimination between weak and strong inhibitors for more than a hundred kinases. Moreover, the relative performance of distinct modeling strategies is systematically analyzed under varying training conditions, and practical guidelines are reported. Since explainable model decisions are a clear requirement for the utility of ML bioactivity models in pharmaceutical research, methods for the interpretation and intuitive visualization of activity predictions from any ML or DL model are introduced. Taken together, this dissertation presents contributions that advance in the application and rationalization of ML models for biological activity and SAR predictions

Network-driven strategies to integrate and exploit biomedical data

[eng] In the quest for understanding complex biological systems, the scientific community has been delving into protein, chemical and disease biology, populating biomedical databases with a wealth of data and knowledge. Currently, the field of biomedicine has entered a Big Data era, in which computational-driven research can largely benefit from existing knowledge to better understand and characterize biological and chemical entities. And yet, the heterogeneity and complexity of biomedical data trigger the need for a proper integration and representation of this knowledge, so that it can be effectively and efficiently exploited. In this thesis, we aim at developing new strategies to leverage the current biomedical knowledge, so that meaningful information can be extracted and fused into downstream applications. To this goal, we have capitalized on network analysis algorithms to integrate and exploit biomedical data in a wide variety of scenarios, providing a better understanding of pharmacoomics experiments while helping accelerate the drug discovery process. More specifically, we have (i) devised an approach to identify functional gene sets associated with drug response mechanisms of action, (ii) created a resource of biomedical descriptors able to anticipate cellular drug response and identify new drug repurposing opportunities, (iii) designed a tool to annotate biomedical support for a given set of experimental observations, and (iv) reviewed different chemical and biological descriptors relevant for drug discovery, illustrating how they can be used to provide solutions to current challenges in biomedicine.[cat] En la cerca d’una millor comprensió dels sistemes biològics complexos, la comunitat científica ha estat aprofundint en la biologia de les proteïnes, fàrmacs i malalties, poblant les bases de dades biomèdiques amb un gran volum de dades i coneixement. En l’actualitat, el camp de la biomedicina es troba en una era de “dades massives” (Big Data), on la investigació duta a terme per ordinadors se’n pot beneficiar per entendre i caracteritzar millor les entitats químiques i biològiques. No obstant, la heterogeneïtat i complexitat de les dades biomèdiques requereix que aquestes s’integrin i es representin d’una manera idònia, permetent així explotar aquesta informació d’una manera efectiva i eficient. L’objectiu d’aquesta tesis doctoral és desenvolupar noves estratègies que permetin explotar el coneixement biomèdic actual i així extreure informació rellevant per aplicacions biomèdiques futures. Per aquesta finalitat, em fet servir algoritmes de xarxes per tal d’integrar i explotar el coneixement biomèdic en diferents tasques, proporcionant un millor enteniment dels experiments farmacoòmics per tal d’ajudar accelerar el procés de descobriment de nous fàrmacs. Com a resultat, en aquesta tesi hem (i) dissenyat una estratègia per identificar grups funcionals de gens associats a la resposta de línies cel·lulars als fàrmacs, (ii) creat una col·lecció de descriptors biomèdics capaços, entre altres coses, d’anticipar com les cèl·lules responen als fàrmacs o trobar nous usos per fàrmacs existents, (iii) desenvolupat una eina per descobrir quins contextos biològics corresponen a una associació biològica observada experimentalment i, finalment, (iv) hem explorat diferents descriptors químics i biològics rellevants pel procés de descobriment de nous fàrmacs, mostrant com aquests poden ser utilitzats per trobar solucions a reptes actuals dins el camp de la biomedicina

Computational Approaches to Drug Profiling and Drug-Protein Interactions

Despite substantial increases in R&D spending within the pharmaceutical industry, denovo drug design has become a time-consuming endeavour. High attrition rates led to a long period of stagnation in drug approvals. Due to the extreme costs associated with introducing a drug to the market, locating and understanding the reasons for clinical failure is key to future productivity. As part of this PhD, three main contributions were made in this respect. First, the web platform, LigNFam enables users to interactively explore similarity relationships between ‘drug like’ molecules and the proteins they bind. Secondly, two deep-learning-based binding site comparison tools were developed, competing with the state-of-the-art over benchmark datasets. The models have the ability to predict offtarget interactions and potential candidates for target-based drug repurposing. Finally, the open-source ScaffoldGraph software was presented for the analysis of hierarchical scaffold relationships and has already been used in multiple projects, including integration into a virtual screening pipeline to increase the tractability of ultra-large screening experiments. Together, and with existing tools, the contributions made will aid in the understanding of drug-protein relationships, particularly in the fields of off-target prediction and drug repurposing, helping to design better drugs faster

Annotation-based storage and retrieval of models and simulation descriptions in computational biology

This work aimed at enhancing reuse of computational biology models by identifying and formalizing relevant meta-information. One type of meta-information investigated in this thesis is experiment-related meta-information attached to a model, which is necessary to accurately recreate simulations. The main results are: a detailed concept for model annotation, a proposed format for the encoding of simulation experiment setups, a storage solution for standardized model representations and the development of a retrieval concept.Die vorliegende Arbeit widmete sich der besseren Wiederverwendung biologischer Simulationsmodelle. Ziele waren die Identifikation und Formalisierung relevanter Modell-Meta-Informationen, sowie die Entwicklung geeigneter Modellspeicherungs- und Modellretrieval-Konzepte. Wichtigste Ergebnisse der Arbeit sind ein detailliertes Modellannotationskonzept, ein Formatvorschlag für standardisierte Kodierung von Simulationsexperimenten in XML, eine Speicherlösung für Modellrepräsentationen sowie ein Retrieval-Konzept

Development and Interpretation of Machine Learning Models for Drug Discovery

In drug discovery, domain experts from different fields such as medicinal chemistry, biology, and computer science often collaborate to develop novel pharmaceutical agents. Computational models developed in this process must be correct and reliable, but at the same time interpretable. Their findings have to be accessible by experts from other fields than computer science to validate and improve them with domain knowledge. Only if this is the case, the interdisciplinary teams are able to communicate their scientific results both precisely and intuitively. This work is concerned with the development and interpretation of machine learning models for drug discovery. To this end, it describes the design and application of computational models for specialized use cases, such as compound profiling and hit expansion. Novel insights into machine learning for ligand-based virtual screening are presented, and limitations in the modeling of compound potency values are highlighted. It is shown that compound activity can be predicted based on high-dimensional target profiles, without the presence of molecular structures. Moreover, support vector regression for potency prediction is carefully analyzed, and a systematic misprediction of highly potent ligands is discovered. Furthermore, a key aspect is the interpretation and chemically accessible representation of the models. Therefore, this thesis focuses especially on methods to better understand and communicate modeling results. To this end, two interactive visualizations for the assessment of naive Bayes and support vector machine models on molecular fingerprints are presented. These visual representations of virtual screening models are designed to provide an intuitive chemical interpretation of the results